{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:26:23Z","timestamp":1774581983546,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013711","name":"Bayer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["267436"],"award-info":[{"award-number":["267436"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cjco.2023.03.010","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T04:07:02Z","timestamp":1679544422000},"page":"530-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adherence to Cardiovascular Prevention Guidelines in an Academic Centre"],"prefix":"10.1016","volume":"5","author":[{"given":"Iness","family":"Soltani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7661-8198","authenticated-orcid":false,"given":"Marie-Claude","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maude","family":"Sestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hillani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Matteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-9026","authenticated-orcid":false,"given":"Brian J.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"395","key":"10.1016\/j.cjco.2023.03.010_bib1","first-page":"1","article-title":"Mortality in the United States, 2019","author":"Kochanek","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.cjco.2023.03.010_bib2","first-page":"e195","article-title":"A\u00a0review of the cost of cardiovascular disease","volume":"25","author":"Tarride","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib3","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2023.03.010_bib4","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2023.03.010_bib5","first-page":"14","article-title":"Diabetes Canada 2018 clinical practice guidelines: key messages for family physicians caring for patients living with type 2 diabetes","volume":"65","author":"Ivers","year":"2019","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.cjco.2023.03.010_bib6","first-page":"1263","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib7","first-page":"1553","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib8","first-page":"506","article-title":"Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib9","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib10","first-page":"214","article-title":"2018 Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy","volume":"34","author":"Mehta","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCULATIONAHA.117.028888","article-title":"Aspirin monotherapy should not be recommended for cardioprotection in patients with symptomatic peripheral artery disease","volume":"136","author":"Brass","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2023.03.010_bib12","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.cjco.2023.03.010_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/hrt.2010.213710","article-title":"Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe","volume":"97","author":"Cacoub","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2023.03.010_bib14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ejhf.887","article-title":"Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2023.03.010_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017008","article-title":"Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study","volume":"7","author":"Nguyen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjco.2023.03.010_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ahj.2015.05.007","article-title":"The association of in-hospital guideline adherence and longitudinal postdischarge mortality in older patients with non-ST-segment elevation myocardial infarction","volume":"170","author":"Shah","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2023.03.010_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gheart.2016.06.001","article-title":"Secondary CV prevention in South America in a community setting: the PURE study","volume":"12","author":"Avezum","year":"2017","journal-title":"Glob Heart"},{"key":"10.1016\/j.cjco.2023.03.010_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ahj.2014.06.007","article-title":"Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from The Guideline Advantage","volume":"168","author":"Eapen","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2023.03.010_bib19","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2013.01.044","article-title":"Risk factor control for coronary artery disease secondary prevention in large randomized trials","volume":"61","author":"Farkouh","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2018.10.001","article-title":"Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: the BRIDGE-Cardiovascular Prevention Trial","volume":"207","author":"Machline-Carrion","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2023.03.010_bib21","article-title":"Cumulative adherence to secondary prevention guidelines and mortality after acute myocardial infarction","volume":"9","author":"Solomon","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjco.2023.03.010_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2023.03.010_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cjco.2020.10.006","article-title":"Exploring new models for cardiovascular risk reduction: the Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada pilot study","volume":"3","author":"Schwalm","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2023.03.010_bib24","first-page":"38","article-title":"Adherence of cardiologist physicians to the American Heart Association guideline in approach to risk factors of cardiovascular diseases: an experience from a teaching hospital","volume":"15","author":"Hosseinzadeh-Shanjani","year":"2019","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.cjco.2023.03.010_bib25","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"118","author":"Bhatt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2023.03.010_bib26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2023.03.010_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.17269\/s41997-020-00320-7","article-title":"Communicating risks to drinkers: testing alcohol labels with a cancer warning and national drinking guidelines in Canada","volume":"111","author":"Hobin","year":"2020","journal-title":"Can J Public Health"},{"key":"10.1016\/j.cjco.2023.03.010_bib28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.cjco.2023.03.010_bib29","first-page":"1027","article-title":"Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial","volume":"33","author":"Bosch","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2023.03.010_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2023.03.010_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2023.03.010_bib32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2023.03.010_bib33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/ejhf.1596","article-title":"Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved trial","volume":"21","author":"Anker","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2023.03.010_bib34","first-page":"973","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"382","author":"McMurray","year":"2020","journal-title":"Reply. N Engl J Med"},{"key":"10.1016\/j.cjco.2023.03.010_bib35","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2023.03.010_bib36","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2023.03.010_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000154568.43333.82","article-title":"National study of physician awareness and adherence to cardiovascular disease prevention guidelines","volume":"111","author":"Mosca","year":"2005","journal-title":"Circulation"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X23000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X23000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:11:26Z","timestamp":1762902686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X23000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2589790X23000641"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2023.03.010","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to Cardiovascular Prevention Guidelines in an Academic Centre","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2023.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}